| 中文别名 |
氟罗沙星;6,8-二氟-1-(2-氟乙基)-1,4-二氢-7-(4-甲基-1-哌嗪基)-4-氧-3-喹啉羧酸;L-赖氨酸苄酯盐酸盐;氟罗沙星 标准品;氟罗沙星(属广谱抗菌药);氟洛沙星;盐酸氟罗沙星;盐酸氟罗沙星,BR;多氟沙星;多氟哌酸;6,8-二氟-1-(2-氟乙基)-7-(4-甲基-1-哌嗪基)-1,4-二氢-4-氧代-3-喹啉羧酸;氟罗沙星,Fleroxacin,分析标准品;三氟沙星;沃尔得片;6,8-二氟-1-(2-氟乙基)1,4-二氢-7-(4-甲基-1-哌嗪基)-4-氧代-3-喹啉羧酸;6,8-二氟-1-(2-氟乙基)1,4-二氢-7-(4-甲基哌嗪)-4-氧代-3-喹啉羧酸 |
| 英文别名 |
Fleroxacin;6,8-difluoro-1-(2-fluoroethyl)-1,4-dihydro-7-(4-methylpiperazino)-4-oxo-3-quinolinecarboxylic acid;AM-833;AM-833 RO 23-6240;6,8-Difluoro-1-(2-Fluoroethyl)-1,4-Dihydro-7-(4-Methyl-1-Piperazinyl)-4-Oxo-3-Quinolinecarboxylic Acid;000;3-quinolinecarboxylicacid,1,4-dihydro-6,8-difluoro-1-(2-fluoroethyl)-7-(4-met;6,8-difluoro-1-(2-fluoro-ethyl)-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid;6,8-difluoro-1-(2-fluoroethyl)-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxoquinoli;6,8-difluoro-1-(2-fluoroethyl)-7-(4-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid;AM833;MEGALOCIN;MEGALONE;QUINODIS;ro23-6240;RO-23-6240;Fleroxacinum;Fleroxacino;Fleroxicin;Fleroxacine;Fleroxacine [French];Fleroxacinum [Latin];Fleroxacino [Spanish];AM 833;Fleroxacin (Quinodis);C17H18F3N3O3;N804LDH51K;6,8-difluoro-1-(2-fluoroethyl)-7-(4-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic ac;RO 23-6240;AB00640001-02;Megalosin;Tox21_112553_1;SR-01000759379-3;MLS006010715;SCHEMBL48145;Ro-236240000;MFCD00864880;A839732;SY057457;ZINC03786299;Tox21_112553;3-Quinolinecarboxylic acid, 6,8-difluoro-1-(2-fluoroethyl)-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-;XBJBPGROQZJDOJ-UHFFFAOYSA-N;NS00005485;FLEROXACIN [MART.];6,8-Difluoro-1-(2-fluoroethyl)-7-(4-methyl-1-piperazinyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid;Fleroxacin (JAN/USAN/INN);D01716;HY-B0414;SMR000466302;Ro 23-6240/000;F0646;NCGC00167558-01;FLEROXACIN [USAN];Fleroxacin [USAN:INN:BAN:JAN];6,8-difluoro-1-(2-fluoroethyl)-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid-;79660-53-0;RO 23-6240;AM-833;MLS000759401;HMS3715B11;6,8-difluoro-1-(2-fluoroethyl)-7-(4-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid;FLRX;Ro-236240;FLEROXACIN [INN];HMS2090I08;3-Quinolinecarboxylic acid, 1,4-dihydro-6,8-difluoro-1-(2-fluoroethyl)-7-(4-methyl-1-piperazinyl)-4-oxo-;CHEMBL6273;DTXCID9026714;KS-5124;6,8-difluoro-1-(2-fluoroethyl)-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylicacid;CCG-221125;79660-72-3;AKOS015907011;Ro-23-6240/000;FLEROXACIN [WHO-DD];AB00640001_04;DB04576;FLEROXACIN [MI];Megalocin (TN);GTPL12476;NCGC00167558-02;CCRIS 3972;Fleroxacin, VETRANAL(TM), analytical standard;Q3746573;6,8-difluoro-1-(2-fluoroethyl)-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid;DTXSID1046714;Megalone (TN);SR-01000759379-2;6,8-difluoro-1-(2-fluoroethyl)-7-(4-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid;Fleroxacin;FT-0630874;s2469;SR-01000759379;BCP28939;FLEROXACIN [JAN];CAS-79660-72-3;CHEBI:31810;UNII-N804LDH51K;AB00640001-03;Fleroxacin,(S);BRN 4300996;RKL10075;BDBM50247892;6,8-Difluoro-1-(2-fluoroethyl)-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid (ACI);Flerofloxacin;MeSH ID: D016576;BRD-K61717546-001-04-3;BRD-K61717546-001-05-0 |
